PENLAN PHARMACEUTICALS LIMITED

07771485
Active Liphook

Wholesale of pharmaceutical goods

2 employees website.com
Wholesale of pharmaceutical goods
P

PENLAN PHARMACEUTICALS LIMITED

07771485

Wholesale of pharmaceutical goods

Founded 13 Sept 2011 Active Liphook, United Kingdom 2 employees website.com
Wholesale of pharmaceutical goods

Previous Company Names

PHARMASAVINGS LIMITED 3 Jan 2012 — 27 Jan 2016
WARNEFORD ASSOCIATES LIMITED 13 Sept 2011 — 3 Jan 2012
Accounts Submitted 6 Oct 2025 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 13 Oct 2025 Next due 14 Oct 2026 3 months remaining
Net assets £-1M £166K 2024 year on year
Total assets £441K £381K 2024 year on year
Total Liabilities £2M £547K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Chiltlee Manor Haslemere Road Liphook Hampshire GU30 7AZ

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PENLAN PHARMACEUTICALS LIMITED (07771485), an active company based in Liphook, United Kingdom. Incorporated 13 Sept 2011. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type micro-entity
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

-£1.42M

Decreased by £165.97k (-13%)

Total Liabilities

£1.86M

Increased by £546.76k (+42%)

Turnover

N/A

Employees

2

Debt Ratio

422%

Decreased by 1747 (-81%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 20 Shares £20 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
15 Jul 201520£20£1

Officers

Officers

2 active 1 resigned
Status
Simon Paul RaynorDirectorBritishUnited Kingdom6013 Sept 2011Active
Stephen Jeremy MartinDirectorBritishUnited Kingdom6115 Jul 2015Active

Shareholders

Shareholders (12)

Penlan Healthcare Limited
58.3%
70
Penlan Healthcare Limited
58.3%
70

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent

Group Structure

Group Structure

PENLAN PHARMACEUTICALS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
13 Oct 2025Confirmation StatementConfirmation statement made on 30 Sept 2025 with updates
6 Oct 2025AccountsAnnual accounts made up to 31 Dec 2024
18 Oct 2024OfficersAppointment of Simon Paul Raynor as director on 18 Oct 2024
18 Oct 2024OfficersTermination of Anthony Brian Bratt as director on 18 Oct 2024
13 Oct 2024Confirmation StatementConfirmation statement made on 30 Sept 2024 with no updates
13 Oct 2025 Confirmation Statement

Confirmation statement made on 30 Sept 2025 with updates

6 Oct 2025 Accounts

Annual accounts made up to 31 Dec 2024

18 Oct 2024 Officers

Appointment of Simon Paul Raynor as director on 18 Oct 2024

18 Oct 2024 Officers

Termination of Anthony Brian Bratt as director on 18 Oct 2024

13 Oct 2024 Confirmation Statement

Confirmation statement made on 30 Sept 2024 with no updates

Recent Activity

Latest Activity

Confirmation statement made on 30 Sept 2025 with updates

8 months ago on 13 Oct 2025

Annual accounts made up to 31 Dec 2024

9 months ago on 6 Oct 2025

Appointment of Simon Paul Raynor as director on 18 Oct 2024

1 years ago on 18 Oct 2024

Termination of Anthony Brian Bratt as director on 18 Oct 2024

1 years ago on 18 Oct 2024

Confirmation statement made on 30 Sept 2024 with no updates

1 years ago on 13 Oct 2024